Vaccines

Mar 06, 2015
The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.
Jan 23, 2015
Pharmaceutical Technology
Government and industry efforts to address manufacturing challenges move Ebola vaccine candidates into larger clinical trials.
Dec 15, 2014
Pharmaceutical Technology
The development and approval of new vaccines and antivirals to contain and treat the Ebola virus outbreak has become a top priority for the federal government and Congress, as seen in new policies to spur R&D and added funding for these efforts.
Dec 15, 2014
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Baxter announced that it had entered into an agreement to sell its Vero cell technology and related assets to Nanotherapeutics.
Dec 11, 2014
Pharmaceutical Technology
By Pharmaceutical Technology Editors
US Department of Health and Human Services announced a declaration to provide immunity to legal claims made in the US in relation to three investigational Ebola vaccines.
Dec 04, 2014
Pharmaceutical Technology
No evidence that Fluad vaccine caused deaths in Italy, says EMA.
Dec 01, 2014
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Dalton Pharma Services announced it was awarded funding from ISTPCanada for its project to develop vaccines for respiratory syncytial virus and parainfluenza type 3.
Nov 25, 2014
By Pharmaceutical Technology Editors
Merck announced an agreement with NewLink Genetics to acquire exclusive rights to its experimental Ebola vaccine, rVSV-EBOV, for $50 million.
Oct 27, 2014
The divestment will create the number two player in the global influenza vaccine industry.
Oct 24, 2014
By Pharmaceutical Technology Editors
Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an Ebola vaccine.
native1_300x100
lorem ipsum